ReneuRx™ (Nerve Selective Therapy) Utilized in Lateral Hip Pain | MicrobiomeTrials← Back to trialsNCT07568015
ReneuRx™ (Nerve Selective Therapy) Utilized in Lateral Hip Pain
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-07-27Est. Completion: 2027-11-01
Enrollment target: 100 participants Locations- Healthcare Outcomes Performance Company, Sun City, Arizona, United States
- Emory Orthopedics and Spine Center, Johns Creek, Georgia, United States
- Ochsner Health Center, New Orleans, Louisiana, United States
- Skylight Health Research, Burlington, Massachusetts, United States
- Mass General Brigham, Chestnut Hill, Massachusetts, United States
- Virtua Health, Sewell, New Jersey, United States
- The Orthopaedic Center, Tulsa, Oklahoma, United States
- Rothman Orthopaedics, King of Prussia, Pennsylvania, United States
- Pain Diagnostics & Interventional Care, Sewickley, Pennsylvania, United States
- University of Texas Southwestern Medical Center, Dallas, Texas, United States
- All-American Orthopedic & Sports, Houston, Texas, United States
Other microbiome trials you might be interested in
GTPS - Greater Trochanteric Pain SyndromeGluteal TendinopathyTrochanteric BursitisLateral Hip Pain
The HIPS-study will be an observer blinded, single-centre, parallel-group randomized controlled trial (RCT).
The main p…
Oslo, NorwayCompleted Oct 22, 2026
Greater Trochanteric Pain Syndrome
Greater trochanteric pain syndrome causes pain on the outer side of the hip. This study examined whether adding high-int…
Uşak, Turkey (Türkiye)Completed Aug 14, 2026